The cost of measles in industrialised countries.


Carabin, H; Edmunds, WJ; Gyldmark, M; Beutels, P; Levy-Bruhl, D; Salo, H; Griffiths, UK; (2003) The cost of measles in industrialised countries. Vaccine, 21 (27-30). pp. 4167-77. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00534-6

Full text not available from this repository. (Request a copy)

Abstract

The aim of this study is to estimate the costs of measles and measles control in 11 industrialised countries with varying levels of measles vaccine coverage. Country-specific annual incidence of measles, measles immunization policy, coverage and costs data were collected. The average societal costs of measles cases and immunisation programme per capita were calculated. These 11 countries spend together over US$ 151 million every year to treat and control measles. Per capita costs of measles control tend to be higher in countries with poorer measles control programmes (for instance, Italy has the highest incidence and highest overall costs), though many other factors, such as the number of antigens given per clinic visit and the local price of MMR also affect the efficiency of the programme. The costs estimates presented here can be used to estimate potential savings that might accrue from changes to measles control programmes.

Item Type: Article
Faculty and Department: Faculty of Public Health and Policy > Dept of Global Health and Development
Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
Vaccine Centre
PubMed ID: 14505896
Web of Science ID: 186830800012
URI: http://researchonline.lshtm.ac.uk/id/eprint/11400

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
308Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item